Boltz Bio joins A-Alpha Bio’s new biomolecular data consortium with GSK and Cradle Bio
GabriCorso · x · 2026-07-22
Boltz Bio joins a new biomolecular data consortium led by A-Alpha Bio
GabriCorso says Boltz Bio is a founding member of a new data consortium organized by A-Alpha Bio, alongside GSK, Cradle Bio, and Dyno Therapeutics.
The stated goal is to generate high-value training data for generalizable biomolecular foundation models. The post argues that consortia can be a strong way to create data that benefits both partners and society.
Related event: Boltz Bio Joins AI Drug Discovery Data Consortium(4 posts)→
More from Companies & People
- OpenClaw and Mac Mini hype fades: buyers spent thousands for nothing — 0xAllen_ · 2026-10-27
- OpenAI releases Signals dataset comparing ChatGPT work usage across nearly 100 countries — soumitrashukla9 · 2026-10-27
- Airbnb CEO Chesky: pure people managers and change-resisters won't survive the AI era — fortune · 2026-10-27
- Interpretability researchers call for a 'Human Genome Project for AI'; author joins Goodfire — ninamiolane · 2026-10-27
- AIE Code Summit 2026 opens applications: 800 seats, keynotes streamed free — trq212 · 2026-10-27
- After Microsoft's 60K layoffs, pundit predicts 50-60% headcount cuts at big companies — krishnan · 2026-10-27